These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2640441)

  • 1. Recent advances in cancer research: drug targeting without the use of monoclonal antibodies.
    Faulk WP; Harats H; McIntyre JA; Berczi A; Sun IL; Crane FL
    Am J Reprod Immunol; 1989; 21(3-4):151-4. PubMed ID: 2640441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells.
    Faulk WP; Barabas K; Sun IL; Crane FL
    Biochem Int; 1991 Dec; 25(5):815-22. PubMed ID: 1666508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence in support of the plasma membrane as the target for transferrin-adriamycin conjugates in K562 cells.
    Barabas K; Sizensky JA; Faulk WP
    Am J Reprod Immunol; 1991 Apr; 25(3):120-3. PubMed ID: 1930638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells.
    Berczi A; Barabas K; Sizensky JA; Faulk WP
    Arch Biochem Biophys; 1993 Jan; 300(1):356-63. PubMed ID: 8424669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates.
    Sun IL; Sun EE; Crane FL; Morré DJ; Faulk WP
    Biochim Biophys Acta; 1992 Mar; 1105(1):84-8. PubMed ID: 1567898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a doxorubicin-transferrin conjugate with isolated transferrin receptors.
    Ruthner M; Berczi A; Goldenberg H
    Life Sci; 1994; 54(1):35-40. PubMed ID: 8255167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients.
    Faulk WP; Taylor CG; Yeh CJ; McIntyre JA
    Mol Biother; 1990 Mar; 2(1):57-60. PubMed ID: 2334538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diferric transferrin reductase in the plasma membrane is inhibited by adriamycin.
    Sun IL; Navas P; Crane FL; Morré DJ; Löw H
    Biochem Int; 1987 Jan; 14(1):119-27. PubMed ID: 3566771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transferrin conjugates in the anticancer therapy].
    Lubgan D; Marczak A; Distel L; Jóźwiak Z
    Postepy Biochem; 2006; 52(1):72-9. PubMed ID: 16869304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor-mediated endocytosis.
    Bérczi A; Ruthner M; Szüts V; Fritzer M; Schweinzer E; Goldenberg H
    Eur J Biochem; 1993 Apr; 213(1):427-36. PubMed ID: 8477715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-reducing activity of plasma membranes.
    Berczi A; Faulk WP
    Biochem Int; 1992 Dec; 28(4):577-84. PubMed ID: 1482396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplasma membrane electron and proton transport is inhibited by chloroquine.
    Toole-Simms W; Sun IL; Morré DJ; Crane FL
    Biochem Int; 1990; 21(4):761-9. PubMed ID: 2173587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
    Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.
    Eavarone DA; Yu X; Bellamkonda RV
    J Biomed Mater Res; 2000 Jul; 51(1):10-4. PubMed ID: 10813739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transplasma membrane electron transport by monoclonal antibodies to the transferrin receptor.
    Toole-Simms W; Sun IL; Faulk WP; Löw H; Lindgren A; Crane FL; Morré DJ
    Biochem Biophys Res Commun; 1991 May; 176(3):1437-42. PubMed ID: 2039523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplasmalemma electron transport from cells is part of a diferric transferrin reductase system.
    Löw H; Sun IL; Navas P; Grebing C; Crane FL; Morre DJ
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1117-23. PubMed ID: 3767994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the anti-cancer activity of transferrin-adriamycin conjugates.
    Sizensky JA; Barabas K; Faulk WP
    Am J Reprod Immunol; 1992; 27(3-4):163-6. PubMed ID: 1418408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates.
    Flanagan PA; Kopecková P; Kopecek J; Duncan R
    Biochim Biophys Acta; 1989 Oct; 993(1):83-91. PubMed ID: 2804126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing of human tumor cells in culture with adriamycin conjugates of human transferrin.
    Yeh CJ; Faulk WP
    Clin Immunol Immunopathol; 1984 Jul; 32(1):1-11. PubMed ID: 6329566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of iron from diferric transferrin in the presence of rat liver plasma membranes: no evidence of a plasma membrane diferric transferrin reductase.
    Thorstensen K; Aisen P
    Biochim Biophys Acta; 1990 Apr; 1052(1):29-35. PubMed ID: 2157501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.